FDA Inspection 1341124 — Medix Biochemica USA, Inc.
The FDA completed an inspection of Medix Biochemica USA, Inc. on Sep 29, 2026 in Maryland Heights, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 29, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Maryland Heights, MO (United States)